haemophilia


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to haemophilia: Haemophilia C

haemophilia

(US), hemophilia
an inheritable disease, usually affecting only males but transmitted by women to their male children, characterized by loss or impairment of the normal clotting ability of blood so that a minor wound may result in fatal bleeding
www.hemophilia.org
References in periodicals archive ?
The pivotal guardian(TM) clinical programme was one of the largest and most comprehensive preregistration clinical trial programmes in haemophilia A, with more than 210 patients with severe haemophilia A treated.
Haemophilia is an inherited condition that influences the blood's ability to clot.
Haemophilia is a genetic disease affecting over 6,800 people in the UK and around 400,000 worldwide.
This research service focuses on the global haemophilia therapeutics market, with a particular focus on recently FDA-approved drugs and late-stage compounds for the treatment of haemophilia A, haemophilia B, inhibitors, and von Willebrand Disease.
Even as the country emphasizes on headline-grabbing ailments, haemophilia, a little known blood disorder, is turning out to be a plague with over 50,000 people affected.
A Canada High Commission release said the event will provide physicians, nurses and families of patients suffering from haemophilia with important information about the diagnosis and management of the disease and will help raise the profile of haemophilia within the Delhi medical community.
The management of haemophilia in developed countries has proceeded through hospital treatment, home therapy, secondary prophylaxis to most costly but very effective primary prophylaxis.
Fore Pharma's latest report 'Global Haemophilia Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Haemophilia market.
Do inhibitors, treatment regimen and bleed frequency impact parent-directed haemophilia treatment centre and provider utilisation: An analysis of parents of children with haemophilia in the HERO study.
The haemophilia comprehensive care model, which is defined as the continuing supervision of all medical and psychosocial factors affecting patients and their families, has been a cornerstone and one of the most successful health programmes in developed countries, resulting in a significant improvement of health and, ultimately, of life expectancy for haemophilia community (6,7).
For Pharma's latest report Global Haemophilia Drug Pipeline Capsule - 2011' is an outline of all the key research and development (R&D) activities of the global haemophilia drug market.
Today, Novo Nordisk announced a new analysis of phase 3 data demonstrating people with haemophilia A who had the highest annualised bleeding rate (ABR) during initial treatment with NovoEight[sup.